iShares Biotechnology ETF IBB

Morningstar Medalist Rating

Morningstar’s Analysis IBB

Will IBB outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Biotechnology ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IBB

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings51.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Gilead Sciences Inc

9.01997M
Healthcare

Amgen Inc

8.50940M
Healthcare

Vertex Pharmaceuticals Inc

7.76859M
Healthcare

Regeneron Pharmaceuticals Inc

6.58727M
Healthcare

Moderna Inc

5.67627M
Healthcare

argenx SE ADR

3.70410M
Healthcare

Natera Inc

2.98330M
Healthcare

Biogen Inc

2.58285M
Healthcare

BeOne Medicines Ltd ADR

2.43269M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.31255M
Healthcare

Sponsor Center